sábado, 15 de agosto de 2015

OTC Lipitor? Why Pfizer made the right decision for the wrong reason.

There were several news stories recently that reported that Pfizer had abandoned its efforts to have its Lipitor brand of atorvastatin made available over the counter (OTC), without a prescription. I was never a big fan of OTC statins, but I was struck by the reason that Pfizer put out: The study did not meet its primary […]

via Medicine Joint Channels

No hay comentarios:

Publicar un comentario